State regulations associated with late-stage cancer diagnoses
the ONA take:
According to a new study conducted by researchers at Georgia State University's School of Public Health in Atlanta and the University of North Carolina at Chapel Hill, state regulations of health insurance and practitioners are significantly associated with time receive breast or colorectal cancer diagnoses.
For the study, researchers evaluated states' regulatory policies and cancer cases reported between 2004 and 2009 in 40 states using the United States Cancer Statistics (USCS) database.
Results showed that 54% to 60% of newly diagnoses cases of colorectal cancer are diagnosed as late-stage cancer, and 24% to 36% of newly diagnosed breast cancers are diagnosed as late-stage.
Of note, the study was conducted between 2010 when the Affordable Care Act was enacted, making cancer screenings more widely available to Americans.
The study was published in the journal Health Economics Review.
State regulations of health insurance and practitioners are significantly associated with time receive breast or colorectal cancer diagnoses.
- Novel Blood Test Detects Cancer, Locates Tumor Without Invasive Procedures
- Cabozantinib Activates Innate Immune Response, Eliminating Prostate Cancer
- Shorter Treatment of Breast Cancer with Trastuzumab May Lead to Improved Results
- Colorectal Cancer Rates Increased Sharply Among Generation X and Millennials
- Pneumonia Associated With Common Cold May Cause Fatal Illness in Stem Cell Transplant Recipients
- Early Palliative Care Reduced ICU Use in Patients With Advanced Cancer
- Ginger Extract Raises Antioxidant Levels in Patients Undergoing Chemotherapy
- Nurse Navigators Improve Physician Engagement in Pretreatment Discussions
- Screening Increases Early Palliative Care, Reduces Aggressive EOL Measures
- Antiperspirants/Deodorants and Breast Cancer (Fact Sheet)
- Exercise Improves Coping While Undergoing Chemotherapy for Advanced GI Cancer
- Genetic Similarity to BRCA1/BRCA2 Mutations May Impact Treatment Options
- Evidenced-Based Radiation Treatment Tied to Cost Savings in Early Stage Breast Cancer
- Genome Sequencing Explains Resistance to CTLA-4 and PD-1 Inhibitors in Metastatic Melanoma
- Lifestyle Choices Have Greater Influence on Colon and Rectal Cancer Risk
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|